Publications
- Indications for venous access in oncology - recommendations of national professional societies and current state in the Czech Republic2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation
- Patient treated with third-line palliative therapy with tipiracil / trifluridine2020 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- Regorafenib in the treatment of advanced gastrointestinal stromal tumour +12015 | Publication without faculty affiliation
- Aflibercept in the treatment of metastatic colorectal cancer2014 | Second Faculty of Medicine
- A case study of a patient with advanced, KRAS wild-type colorectal carcinoma, treated with cetuximab2013 | Second Faculty of Medicine
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
Loading network view...
